Back to news overview
  • Helmbrechts
  • 07/03/2024

RAUMEDIC Announces Membership in the Bio-Process Systems Alliance (BPSA)

RAUMEDIC, a global leader in the development and manufacturing of polymer-based components and systems for the medical and pharmaceutical industry, is now a member of the Bio-Process Systems Alliance (BPSA) . This step aligns with RAUMEDIC’s strategic commitment to serve the biopharmaceutical and biotech sectors as a supplier of single-use fluid management equipment.

BPSA is an international non-profit organization led by industry experts spanning the entire value chain of bioprocessing. The global association strives to advance the global adoption of single-use technology in bioprocessing, aiming to realize this mission through educational initiatives, best practice sharing, consensus guideline development, and fostering networking opportunities.

“Joining BPSA reflects our commitment to leading the future by staying at the forefront of industry standards, ensuring our single-use solutions align with the latest advancements and regulations of the industries we serve”, says Stefan Seuferling, CEO of RAUMEDIC AG

Mark A. Petrich, Chairman of the Board of BPSA, is glad to welcome RAUMEDIC as a new member of the organization: 

“We are excited to announce RAUMEDIC as a new member of our global alliance. We recognize the valuable perspective that the German company brings to our organization and its members – especially with their expertise in polymer-based solutions such as single-use sets and tubing.”

RAUMEDIC’s interest in joining BPSA is also based on recent activities to deepen its service to the biopharmaceutical industry - serving as a reliable and safe one-stop-shop for polymeric single-use products. 

Last year, RAUMEDIC launched a new brand for biocompatible single-use bioprocessing tubing. Leveraging more than 70 years of polymer processing expertise, the company decided to end its exclusivity as a supplier of a single major life science client - and offer its single-use solutions to the entire market for the first time.


RAUMEDIC develops solutions for life. Together with its customers, the medical and pharmaceutical technology company breaks new ground to improve the diagnosis and therapy of diseases. In doing so, RAUMEDIC focuses on polymer-based solutions for medical and pharmaceutical applications as well as products for intensive care. RAUMEDIC is represented worldwide and employs around 1,200 people at five production sites. In the core markets of Europe and North America, the company manufactures in its own clean room manufacturing facilities.